Simon Moores , Director of Finance at St. James's Hospital
-
Upload
investnet -
Category
Healthcare
-
view
87 -
download
1
Transcript of Simon Moores , Director of Finance at St. James's Hospital
Strategy & Roadmap for Implementation
Simon MooresDirector of Finance
1. Funding Model for Acute Hospitals
2. Strategy for St James’s Hospital
3. Future Opportunities & Challenges
2
Funding Model for Acute Hospitals
Strategy for St James’s Hospital
Future Opportunities & Challenges
3
4
BLOCK FUNDING
In-Patient & Day Case =
Activity based funding
Emergency & OPD =
Block funding
2015 2016
Actual costs & revenue per patient key
5
6
• Specified Price paid for each Weighted Unit of
in-patient and day case episode of care up to a limit
of specified Activity
National Average Price set by HPO
Historic Activity Level
Complexity of care by DRG
Funding Model for Acute Hospitals
Strategy for St James’s Hospital
Future Opportunities & Challenges
7
Understand and manage costs at patient episode level
To be an international leader in Activity Based Funding
8
9
Appropriate funding & Complexity
Patient level cost visibility
Accountability
10
Funding
Stream
Management
Absolute
Cost
Identification
Allocation &
Cost Driver
Identification
Service Line
Management
11
Directorate Specialty DRGCode Description Case Units
LOS Peer ALOS
Revenue Cost Est.
HOPE
Oncology E71B: Respiratory Neoplasms W/O Catastrophic CC 1.0 27 7 €6,218 €17,391
G47B: Other Gastroscopy W/O Catastrophic CC 0.6 16 5 €2,743 €9,188
S65A: HIV-Related Diseases W Catastrophic CC 5.4 50 29 €38,280 €68,888
Radiotherapy K62B: Miscellaneous Metabolic Disorders W/O Catastrophic or Severe CC
0.8 30 3 €11,542 €16,934
MEDICINE Cardiology F15A: Interventional Coronary Procs W/O AMI W Stent Implantation W Cat or Sev CC
1.5 21 7 €6,477 €26,592
1.5 23 7 €6,477 €29,125
Dermatology J64B: Cellulitis W/O Catastrophic or Severe CC 0.6 15 4 €2,489 €8,254
Gastro Enterology
H61A: Malignancy of Hepatobiliary System, Pancreas W Catastrophic CC
2.0 44 18 €15,665 €25,186
H61B: Malignancy of Hepatobiliary System, Pancreas W/O Catastrophic CC
1.1 46 8 €15,136 €25,001
General Medicine A06A: Tracheostomy W Ventilation >95 hours W Catastrophic CC 25.0 223 84 €244,409 €451,563
L63B: Kidney and Urinary Tract Infections W/O Catastrophic or Severe CC
0.6 43 6 €13,935 €21,863
Q01Z: Splenectomy 2.5 48 9 €28,860 €83,497
X62A: Poisoning/Toxic Effects of Drugs and Other Substances W Cat or Sev CC
0.8 20 6 €3,308 €11,603
Genito Urina F63A: Venous Thrombosis W Catastrophic or Severe CC 1.1 23 12 €4,602 €10,382
Neurology X05A: Other Procedures for Injuries to Hand W CC 0.8 14 3 €5,859 €9,543
Rheumatolog y E62A: Respiratory Infections/Inflammations W Catastrophic CC 2.1 59 22 €19,700 €32,639
E66B: Major Chest Trauma W Severe or Moderate CC 0.8 17 6 €3,368 €6,401
E75A: Other Respiratory System Diagnosis W Catastrophic CC 1.5 62 17 €18,068 €31,654
F76B: Arrhythmia, Cardiac Arrest and Conduction Disorders W/O Cat or Sev CC
0.4 13 3 €1,734 €6,900
J64A: Cellulitis W Catastrophic or Severe CC 1.4 37 15 €9,505 €16,937
12
13
In Patient,
Day Case,
OPD & ED
Cost Drivers
CONSULTANT
TIME
NUMBER
NCHD’s
ANP /
CLINICAL
NURSE
SPECIALIST
WARD COSTS
ALLIED
HEALTH
OTHER
ANCILLARY
SERVICES
ICT Requirement to capture
data?
14
15
Vision
Aims
Strategic Work
Streams
Strategic Enablers
Funding Stream Management
Absolute Cost Identification
Allocation & Cost Drivers
Service Line Management
16
Funding Model for Acute Hospital’s
Strategy for St James’s Hospital
Future Opportunities & Challenges
17
18
• Integrated care pathways
• Insight driven
• Value based healthcare
• Outcome measurement
19
20